NCT07501780 Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice
| NCT ID | NCT07501780 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Maastricht University Medical Center |
| Condition | Basal Cell Carcinoma of Skin |
| Study Type | OBSERVATIONAL |
| Enrollment | 297 participants |
| Start Date | 2026-06-15 |
| Primary Completion | 2027-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 297 participants in total. It began in 2026-06-15 with a primary completion date of 2027-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Basal cell carcinoma (BCC) is the most common skin cancer in the Netherlands, with incidence rates continuing to rise. The current diagnostic standard combines clinical evaluation and dermoscopy, while biopsy followed by histopathological examination remains the gold standard when uncertainty about the diagnosis persists. However, biopsy is invasive, time-consuming, and costly. Line-field confocal optical coherence tomography (LC-OCT) is a non-invasive imaging technique that has emerged as a promising alternative to biopsy for BCC suspected lesions. This retrospective study aims to evaluate the real-world clinical performance of LC-OCT in routine dermatological practice, where it has been integrated into the diagnostic work-up for BCC-suspect lesions.
Eligibility Criteria
Inclusion Criteria: * Patients aged ≥18 years * LC-OCT performed as part of diagnostic evaluation between January 2025 and June 2025 at Mohs clinics in the Netherlands * Histopathological results (biopsy or excision) and/or 6-12 month clinical follow-up data available Exclusion Criteria: * Patients \<18 years of age * Cases without histopathological confirmation or available follow-up data
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07501780 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Basal Cell Carcinoma of Skin. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07501780 currently recruiting?
Yes, NCT07501780 is actively recruiting participants. Contact the research team at yara.valkenburg@mumc.nl for enrollment information.
Where is the NCT07501780 trial being conducted?
This trial is being conducted at Maastricht, Netherlands.
Who is sponsoring the NCT07501780 clinical trial?
NCT07501780 is sponsored by Maastricht University Medical Center. The trial plans to enroll 297 participants.